Aromasin Side Effects: Bone Loss and Fractures. The breast-cancer drug Aromasin, used in trials to prevent the cancer from developing in postmenopausal women, worsened bone loss in these women and raised their risk for fractures, a new study finds. The study was published in the Feb. 6 online edition of The Lancet Oncology.
Pfizer Inc, the world’s biggest drug maker, manufactures the drug.
Gleevec Side Effects. Gleevec, the drug commonly used to treat tumors of the stomach and digestive system, has been approved by United States regulators for expanded use in patients with a rare gastrointestinal cancer — and trials used to gain approval showed that the drug significantly prolonged the lives of patients.
On Jan. 31, the U.S. Food and Drug Administration granted regular approval to Gleevec (imatinib) for use in adult patients following surgical removal of CD117-positive gastrointestinal stromal tumors (GIST).
Herceptin Side Effects. Does the anti-breast cancer drug Herceptin cause weight loss or weight gain? Apparently, it can do either.
However, Herceptin weight loss is much more common than Herceptin weight gain. In fact, weight loss is listed as one of the most common side effects of Herceptin usage. In contrast, Heceptin weight gain is not included in such a list. From herceptin.org:
The most common adverse reactions associated with Herceptin in metastatic gastric cancer were neutropenia, diarrhea, fatigue, anemia, stomatitis, weight loss, upper respiratory tract infections, fever, thrombocytopenia, mucosal inflammation, nasopharyngitis, and dysgeusia.